Introducing Our Quarterly Protein Update!

Next Generation Targets for Immuno-Oncology!
On May 4th Bio-Techne hosted a webinar on Next Generation Targets for Immunotherapy. Bio-Techne scientist, Anthony Person, Ph.D., discussed novel immunoregulatory pathways that the R&D Systems protein group has uncovered as potential targets for cancer immunotherapy. Watch now!

The CTRP Family: Novel TNF-Related Proteins
Structurally related to the TNF superfamily, CTRPs have roles in immunity and metabolism. Our exclusive selection of bioactive CTRP proteins provide the tools to expand on this intriguing research. See our data highlighting CTRP-mediated proliferation, neurite outgrowth, AMPK activation, and more. Learn More!

Recombinant Human CD27 Ligand/TNFSF7
This co-stimulatory protein and modulator of the immune response is a clear immuno-oncology target. R&D Systems now offers HEK293-derived recombinant human CD27 that induces cytokine secretion in the low ng/mL range. Learn More!

R&D Systems Has the Only Commercially Available S100 Heterodimers in the Industry
It is becoming increasingly evident that members of the S100 family are promising targets for a range of human pathologies. R&D Systems has the widest selection of bioactive proteins, including exclusive heterodimers. Learn More!

Coming Soon! GMP Animal-Free^™ TGF-β and Fibronectin!
Fibronectin and TGF-beta are important supplements for growing, maintaining, and differentiating several stem and immune cell types. These proteins will meet needs for ex vivo cell culture in cell therapy manufacturing. Sign up for updates!

New Immuno-Oncology Targets Identified: See the New Ligand for VISTA
The hottest area in cancer right now is immuno-oncology. R&D Systems’ scientists have data to suggest a new ligand for the B7 family member VISTA. See their new scientific poster. Download Now!

R&D Systems is the Only Source for Bioactive Integrin Heterodimers
We are the only company that develops, tests, and sells active integrin heterodimers including popular pharmaceutical targets, such as Integrins α4β7, α2bβ3, αvβ1, αvβ3, αvβ5, and αvβ6. See the latest data and product listings in our new brochure. Download now!